Rezultati - Merlin C Thomas

PPAR Agonists and Cardiovascular Disease in Diabetes od Anna C. Calkin, Merlin C. Thomas

Polni tekst

SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review od Merlin C Thomas, Brendon L Neuen, Stephen M Twigg, Mark E Cooper, Sunil V Badve

Polni tekst

Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial od Samy Hadjadj, Mark E. Cooper, Dominik Steubl, Michaela Petrini, Stefan Hantel, Michaela Mattheus, Christoph Wanner, Merlin C. Thomas

Polni tekst

Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice od Chris Tikellis, Gardner N. Robinson, Carlos J. Rosado, Duygu Batu, Maria A. Zuniga-Gutierrez, Raelene J. Pickering, Merlin C. Thomas

Polni tekst

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes od Ishant Khurana, Harikrishnan Kaipananickal, Scott Maxwell, Sørine Birkelund, Anna Syreeni, Carol Forsblom, Jun Okabe, Mark Ziemann, Antony Kaspi, Haloom Rafehi, Anne Jørgensen, Keith Al-Hasani, Merlin C. Thomas, Guozhi Jiang, Andrea O.Y. Luk, Heung Man Lee, Yu Huang, Yotsapon Thewjitcharoen, Soontaree Nakasatien, Thep Himathongkam, Christopher Fogarty, Rachel Njeim, Assaad Eid, Tine Willum Hansen, Nete Tofte, Evy C. Ottesen, Ronald C.W. Ma, Juliana C.N. Chan, Mark E. Cooper, Peter Rossing, Per-Henrik Groop, Assam El-Osta

Polni tekst